Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)
Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)
Active, not recruiting · NCT04838444 · Registry updated 2026-07-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-07-09 | NCT04838444 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Valneva Austria GmbH | 6 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Accelerated Enrollment Solutions (AES) | Chicago | United States | 1 |
| Accelerated Enrollment Solutions (AES) | Phoenix | United States | 1 |
| Alliance for Multispecialty Research (AMR) | Lexington | United States | 1 |
| Alliance for Multispecialty Research (AMR) | Knoxville | United States | 1 |
| Allliance for Multispecialty Research (AMR) | Norfolk | United States | 1 |
| Velocity Clinical Research | Omaha | United States | 6 |
| Velocity Clinical Research | Grand Island | United States | 2 |
| Velocity Clinical Research | Hallandale | United States | 1 |
| Velocity Clinical Research | West Jordan | United States | 2 |
| Velocity Clinical Research | Austin | United States | 2 |